Selenium Supplementation of Patients With Cirrhosis
Stopped early · Not applicable · Has a placebo group
Conditions studied: Liver Disease
In brief
The purpose of this study is to determine whether patients with liver cirrhosis can improve their selenium nutritional status by taking supplemental selenium.
Key facts
- Study ID
- NCT00271245
- Run by
- Vanderbilt University
- People needed
- 99
- Starts
- 2006-02-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2012-03-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- liver disease
- aged 18 or above
You may not qualify if…
- substance abuse
- renal failure
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.